Pemetrexed Continuation Maintenance versus Conventional Platinum-based Doublet Chemotherapy in EGFR-negative Lung Adenocarcinoma: Retrospective Analysis

被引：0
|
作者：
Hwang, I. K. [1 ]
Paik, S. S. [1 ]
Park, M. J. [2 ]
Lee, S. H. [2 ]
机构：
[1] Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan, South Korea
[2] Kyung Hee Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
pemetrexed; chemotherapy; Platinum;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-020
引用
收藏
页码：S2134 / S2134
页数：1
相关论文
共 50 条
  • [21] First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with EGFR mutation (CONVINCE)
    Shi, Y-K.
    Wang, L.
    Han, B.
    Li, W.
    Yu, P.
    Liu, Y.
    Ding, C.
    Song, X.
    Ma, Z.
    Ren, X.
    Feng, J.
    Zhang, H.
    Chen, G.
    Wu, N.
    Han, X.
    Yao, C.
    Song, Y.
    Zhang, S.
    Ding, L.
    Tan, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy
    Cserepes, Mihaly
    Ostoros, Gyula
    Lohinai, Zoltan
    Raso, Erzsebet
    Barbai, Tamas
    Timar, Jozsef
    Rozsas, Anita
    Moldvay, Judit
    Kovalszky, Ilona
    Fabian, Katalin
    Gyulai, Marton
    Ghanim, Bahil
    Laszlo, Viktoria
    Klikovits, Thomas
    Hoda, Mir Alireza
    Grusch, Michael
    Berger, Walter
    Klepetko, Walter
    Hegedus, Balazs
    Dome, Balazs
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (10) : 1819 - 1828
  • [23] Efficacy of Pemetrexed Maintenance in East-Asian Patients Subgroup Analysis of a Phase III Study Comparing Pemetrexed versus Placebo in Non-Small Cell Lung Cancer (NSCLC) Following Platinum-Based Induction Chemotherapy
    Belani, Chandra P.
    Wu, Yi-Long
    Chen, Yuh-Min
    Kim, Joo-Hang
    Yang, Sung-Hyun
    Zhang, Li
    Peterson, Patrick
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S373 - S373
  • [24] Nivolumab as Maintenance Therapy Following Platinum-Based Chemotherapy in EGFR-mutant Lung Cancer Patients After TKI Failure
    Kim, J.
    Choi, C. -M.
    Lee, J. C.
    Ji, W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S615 - S615
  • [25] Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis
    Tetsuya Isaka
    Hiroyuki Ito
    Haruhiko Nakayama
    Tomoyuki Yokose
    Kayoko Katayama
    Kouzo Yamada
    Munetaka Masuda
    Molecular Diagnosis & Therapy, 2019, 23 : 657 - 665
  • [26] Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis
    Isaka, Tetsuya
    Ito, Hiroyuki
    Nakayama, Haruhiko
    Yokose, Tomoyuki
    Katayama, Kayoko
    Yamada, Kouzo
    Masuda, Munetaka
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (05) : 657 - 665
  • [27] Combination of a three-microRNA signature and TP53 genotype predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma
    Shiraishi, Kouya
    Saito, Motonobu
    Kohno, Takashi
    CANCER RESEARCH, 2015, 75 (22)
  • [28] First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).
    Shi, Yuankai
    Wang, Lin
    Han, Baohui
    Li, Wei
    Yu, Ping
    Liu, Yunpeng
    Ding, Cuimin
    Song, Xia
    Yong, Ma Zhi
    Ren, Xinling
    Feng, Ji Feng
    Zhang, Helong
    Chen, Gongyan
    Wu, Ning
    Han, Xiaohong
    Yao, Chen
    Song, Yong
    Zhang, Shucai
    Ding, Lieming
    Tan, Fenlai
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] THE EFFICACY OF PLATINUM-BASED ADJUVANT CHEMOTHERAPY ACCORDING TO EGFR MUTATION IN THE SURGICALLY RESECTED LUNG ADENOCARCINOMAS
    Kang, Jin Hyoung
    Kim, In-Ho
    Kim, Jung Oh
    Kim, Tae-Jung
    Hong, Sook Hee
    Jeon, Eun Kyoung
    Lee, Kyo-Young
    Sung, Sook Hwan
    Park, Jae Kil
    Kim, Seung Joon
    Kim, Young Kyoon
    Kim, Hoon-Kyo
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S185 - S186
  • [30] Development and validation of a prediction model for myelosuppression in lung cancer patients after platinum-based doublet chemotherapy: a multifactorial analysis approach
    Li, Xueyan
    Li, Linyu
    Zhang, Lu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (02):
12345